Duvelisib monohydrate is the hydrated API form of duvelisib, an oral targeted anticancer drug and a dual PI3K-δ/PI3K-γ inhibitor. It is grouped under the following drug class(es): Antineoplastic agents and Kinase inhibitors. Its therapeutic use is listed as anti-cancer agents. Other names for this substance include Duvelisib hydrate and Copiktra. Its PubChem CID is 137528190.
Duvelisib monohydrate
| CAS No | 1386861-49-9 |
|---|---|
| Molecular Formula | C22H19ClN6O2 |
| Molecular Weight | 434.9 g/mol |
| Synonyms | 8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Duvelisib monohydrate is the hydrated API form of duvelisib, an oral targeted anticancer drug and a dual PI3K-δ/PI3K-γ inhibitor. It is grouped under the following drug class(es): Antineoplastic agents and Kinase inhibitors.
The listed CAS number is 1386861-49-9.
The listed molecular formula is C22H19ClN6O2.
The listed molecular weight is 434.9 g/mol.
8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one;hydrate.
The source lists Duvelisib hydrate and Copiktra.